Food restriction and experimentally-induced
diabetes (streptozotocin) can modify
serotonin (5-HT) neurotransmission and sensitivity to drugs acting on
5-HT systems. This study examined the effects of food restriction and
streptozotocin on the hypothermic effects of the
5-HT(1A) receptor agonist (+)-8-hydroxy-2-(dipropylamino)
tetralin hydrobromide (8-OH-DPAT), the 5-HT(2) receptor agonist (+/-)-
2,5-dimethoxy-4-methylamphetamine hydrochloride (DOM), the
5-HT releaser
fenfluramine, and the selective
5-HT reuptake inhibitor (SSRI)
fluoxetine. All four drugs significantly decreased body temperature in free feeding rats. Limiting rats to 10 g/day of food for 7 days decreased
body weight and sensitivity to
8-OH-DPAT induced hypothermia, without affecting sensitivity to DOM,
fenfluramine, or
fluoxetine induced hypothermia. Subsequently, 7 days of free feeding restored
body weight and sensitivity to
8-OH-DPAT. Sensitivity to all drugs was significantly decreased 7 days after 50 mg/kg
streptozotocin; subsequently, 10 days of
insulin replacement restored sensitivity to all drugs. These results extend to body temperature the observation that food restriction and experimentally-induced diabetes differentially modify sensitivity to drugs acting on
5-HT systems and they further suggest that the clinical response to therapeutic drugs acting on
5-HT systems might be impacted by nutritional and
insulin status.